BestWay Project at Chughtai Lab

BestWay Project at Chughtai Lab

The BestWay Project at Chughtai Lab represents a premier, highly comprehensive diagnostic health screening panel designed to evaluate an individual’s overall physiological status. This wellness profile is meticulously structured to detect early signs of metabolic, cardiovascular, hepatic, renal, and hematological disorders before clinical symptoms manifest. Operating on the principle of preventive medicine, this panel utilizes state-of-the-art automated laboratory technology to analyze key biomarkers in blood and urine samples. In an era where non-communicable diseases such as diabetes, hypertension, and chronic kidney disease are rising globally, proactive health monitoring has transitioned from an optional check-up to a clinical necessity.

At Chughtai Lab, a leading diagnostic network in Pakistan, the BestWay Project is executed under strict quality control protocols. By assessing vital organ systems, including the liver, kidneys, and cardiovascular system, alongside metabolic indicators like blood glucose and hematological parameters, this profile provides a holistic view of a patient’s health. The diagnostic value of this panel lies in its ability to identify risk factors for chronic conditions such as Type 2 Diabetes, hypertension, hyperlipidemia, chronic kidney disease, and fatty liver disease. Early identification allows clinicians to intervene with lifestyle modifications, dietary adjustments, or early therapeutic strategies, significantly reducing long-term morbidity.

The benefits of undergoing the BestWay Project at Chughtai Lab extend beyond simple disease detection. It empowers patients with a comprehensive baseline of their physiological metrics, allowing for personalized healthcare tracking over time. The panel is highly recommended for routine annual health check-ups, corporate wellness evaluations, occupational health screenings, and for individuals with a family history of metabolic or cardiovascular diseases. By choosing Chughtai Lab, patients benefit from a legacy of diagnostic excellence, highly automated laboratory systems, and reports compiled by qualified consultant pathologists.

Clinical Procedure: What to Expect

Patient Preparation

To ensure the utmost accuracy of the biochemical assays included in the BestWay Project, patients must strictly adhere to the following preparation guidelines:

• Fasting: A strict fasting period of 10 to 12 hours is required before sample collection. Only plain water is permitted during this time. Avoid tea, coffee, juices, sodas, and smoking, as these can alter metabolic markers.
• Medication: Consult your referring physician regarding your routine medications. Most maintenance medications for blood pressure or thyroid conditions can be taken with water, but diabetic medications may need to be adjusted due to the fasting state.
• Alcohol and Diet: Avoid consuming alcohol, heavy fatty meals, or engaging in strenuous physical exercise for at least 24 to 48 hours prior to the test, as these can artificially alter lipid profiles and liver enzyme levels.
• Hydration: Drink adequate amounts of plain water to ensure you are well-hydrated. This facilitates easier venous access for the phlebotomist and ensures a proper urine sample can be provided.

During the Procedure

The sample collection process for the BestWay Project at Chughtai Lab is streamlined, hygienic, and minimally invasive. Upon arrival at the collection center or during a home sampling visit, the patient is comfortably seated in a specialized phlebotomy chair. A certified phlebotomist will locate a suitable vein, typically in the antecubital fossa of the inner elbow. The area is thoroughly sanitized with an antiseptic swab to prevent contamination.

A sterile, single-use needle is inserted to collect blood into specific vacuum tubes (including EDTA, Gel, and Fluoride tubes) appropriate for the various hematological and biochemical tests. Once the required volume is obtained, the needle is gently removed, and a small sterile adhesive bandage is applied to the puncture site. For the urine analysis component, the patient is provided with a sterile container and instructed on collecting a mid-stream clean-catch urine specimen. The entire process takes approximately 10 to 15 minutes and is performed under strict biosafety protocols, ensuring patient safety and comfort throughout.

When is a BestWay Project Performed?

Routine Preventive Health Screening

As individuals age, the risk of silent metabolic and cardiovascular disorders increases. Physicians recommend the BestWay Project annually to establish baseline health metrics and track physiological changes over time. This proactive screening helps identify subclinical abnormalities before they progress into chronic diseases, enabling timely lifestyle or medical interventions.

Corporate Wellness and Occupational Health Assessments

Many progressive organizations partner with Chughtai Lab to offer the BestWay Project to their employees. This helps identify occupational health risks, manage stress-related metabolic changes, and promote a healthier, more productive workforce. Regular corporate health tracking reduces absenteeism and fosters a culture of wellness within the workplace.

Evaluation of Unexplained Fatigue and Malaise

Chronic fatigue, lethargy, and general malaise are non-specific symptoms that can stem from anemia, thyroid dysfunction, electrolyte imbalances, or early organ dysfunction. The comprehensive nature of the BestWay Project helps clinicians systematically rule out these underlying causes by evaluating red blood cell parameters, renal function, and metabolic markers.

Monitoring Metabolic and Cardiovascular Risk Factors

Individuals with risk factors such as obesity, a sedentary lifestyle, smoking, or a family history of premature heart disease or diabetes undergo this test to monitor lipid profiles and blood sugar levels. Regular monitoring is crucial for assessing the efficacy of ongoing treatments, dietary changes, or exercise regimens designed to lower cardiovascular risk.

Screening for Early Renal or Hepatic Dysfunction

Liver and kidney diseases often progress silently without noticeable symptoms in their early stages. The BestWay Project evaluates renal waste clearance and liver enzyme activity, allowing for the detection of subclinical organ damage caused by fatty liver disease, medication side effects, or early-stage chronic kidney disease.

What Does a BestWay Project Detect?

The BestWay Project at Chughtai Lab is designed to detect a wide array of physiological abnormalities and markers of disease. Specifically, this comprehensive panel evaluates and detects:

• Anemia and Red Blood Cell Disorders: Identified through Hemoglobin, Hematocrit, and Red Blood Cell indices, helping diagnose iron deficiency, vitamin B12 deficiency, or chronic disease anemia.
• Active Infections or Inflammatory Responses: Detected via Total Leukocyte Count (TLC) and Differential Leukocyte Count (DLC).
• Coagulation and Bleeding Risks: Evaluated through Platelet Count monitoring.
• Impaired Fasting Glucose and Prediabetes: Detected via Fasting Blood Sugar levels, indicating insulin resistance or early-stage diabetes.
• Hypercholesterolemia and Cardiovascular Risk: Evaluated through Total Cholesterol levels.
• Atherogenic Risk from Low-Density Lipoproteins: Detected via elevated LDL Cholesterol, a key driver of arterial plaque formation.
• Protective Lipid Levels: Evaluated through HDL Cholesterol, which helps clear cholesterol from the bloodstream.
• Hypertriglyceridemia: Detected via Triglyceride levels, which are linked to metabolic syndrome and pancreatitis.
• Hepatocellular Injury or Inflammation: Detected via elevated Alanine Aminotransferase (ALT/SGPT) and Aspartate Aminotransferase (AST/SGOT) enzymes.
• Biliary Tract Obstruction or Bone Turnover Markers: Evaluated through Alkaline Phosphatase (ALP) levels.
• Systemic Liver Function and Protein Synthesis: Assessed via Serum Albumin and Total Protein levels.
• Bilirubin Metabolism and Hemolytic Disorders: Evaluated through Total, Direct, and Indirect Bilirubin levels.
• Renal Filtration Efficiency and Waste Clearance: Detected via Serum Creatinine and estimated Glomerular Filtration Rate (eGFR).
• Protein Metabolism Waste Accumulation: Evaluated through Blood Urea levels, indicating kidney function or hydration status.
• Purine Metabolism Disorders and Gout Risk: Detected via elevated Serum Uric Acid levels.
• Urinary Tract Infections (UTIs): Identified through the presence of Urine Leukocytes, Nitrites, and Bacteria in the urine analysis.
• Renal Parenchymal Damage or Glomerular Leakage: Detected via Urine Protein (Proteinuria).
• Renal Threshold Excretion of Glucose: Detected via Urine Glucose (Glucosuria), often indicating uncontrolled diabetes.
• Microscopic Hematuria: Detected via Urine Red Blood Cells, which may indicate urinary tract stones, infection, or malignancy.
• Presence of Urinary Crystals: Evaluated via Urine Microscopy, indicating a predisposition to kidney stone formation.

Turnaround Time and Report Access at Chughtai Lab

Chughtai Lab is renowned for its efficient reporting and advanced digital infrastructure. For the BestWay Project, which comprises multiple biochemical and hematological assays, reports are typically finalized within 12 to 24 hours of sample collection. Patients receive an automated SMS notification once the results are verified by a consultant pathologist. Reports can be accessed online via the official Chughtai Lab website portal, through the dedicated Chughtai Lab mobile application, or via WhatsApp. Physical copies can also be collected from any of the numerous Chughtai Lab collection centers across Pakistan, or delivered directly to the patient’s home through their reliable home delivery service.

BestWay Project Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Fasting Blood Glucose	70–100 mg/dL	Elevated (Hyperglycemia/Diabetes), Decreased (Hypoglycemia)
Total Cholesterol	< 200 mg/dL	Elevated (Hypercholesterolemia/Cardiovascular risk)
Serum Creatinine	0.6–1.2 mg/dL (adults)	Elevated (Renal impairment/Kidney dysfunction)
Alanine Aminotransferase (ALT)	< 45 U/L (varies by gender)	Elevated (Hepatocellular injury, fatty liver, hepatitis)
Hemoglobin	12.0–16.0 g/dL (females), 13.5–17.5 g/dL (males)	Decreased (Anemia), Elevated (Polycythemia)
Blood Urea	15–45 mg/dL	Elevated (Dehydration, renal failure, high protein intake)
Urine Protein	Negative	Positive (Proteinuria, glomerular disease, kidney damage)
Triglycerides	< 150 mg/dL	Elevated (Hypertriglyceridemia, metabolic syndrome risk)

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Chughtai Lab for BestWay Project?

• Experienced Healthcare Professionals: Samples are processed by highly trained laboratory technologists and reviewed by Consultant Pathologists.
• Patient-Focused Care: Providing a compassionate, professional, and comfortable environment for all diagnostic procedures.
• Quality Diagnostic Services: Adhering to strict international quality control standards to ensure accurate and reliable results.
• Professional Reporting: Comprehensive, easy-to-read reports with clear reference ranges for accurate clinical interpretation.
• Modern Diagnostic Approach: Utilizing fully automated chemistry, hematology, and immunoassay analyzers from world-renowned manufacturers.
• Comfortable Environment: Modern, clean, and welcoming collection centers designed with patient comfort in mind.
• Convenient Location: A vast nationwide network of collection centers makes accessing quality diagnostics easy across Pakistan.
• Commitment to Accurate Diagnosis: Dedicated to providing precise diagnostic insights that empower patients and clinicians to make informed health decisions.